Skip to main content

Illinois IGB

CCIL

Erik Nelson - A milestone in my career

February 20, 2023

Several days following the Federal Drug Administration’s approval of a new cancer drug, Erik Nelson (ACPP) was still processing the news.

“It hasn’t sunk in yet that this is actually happening,” he said from his breast cancer research lab in Burrill Hall. “This is why I get up every morning: to hopefully impact a patient's life.”


February 20, 2023


Related Articles

Researchers target prostate cancer with new, rapid biomarker detection method

February 7, 2023

The pivotal role of microRNA in diagnosing and monitoring cancer is well known by today’s researchers. “There have been a lot of studies in recent years linking the presence and concentration of specific microRNA sequences to clinical outcomes for people with advanced prostate cancer,” said Brian Cunningham (CGD leader/MMG), a professor of electrical and computer engineering and a program leader at the Cancer Center at Illinois.


February 7, 2023


Related Articles

Subscribe to CCIL